Ameliorative Effect of Nanoparticles with Trials for Treatment Against Diabetic Hepatopathy Systemic Review

RECENT APPROACHES FOR SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS IN THE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE

EUGENOL AMELIORATES PATHOGENIC FEATURES IN EXPERIMENTAL MODEL OF NAFLD IN RATS

AMELIORATIVE EFFECT OF PIOGLITAZONE AND ROUSVASTATIN ON HFD/STZ-INDUCED HEPATIC INJURY IN RATS

Protective effect of dapagliflozin against non-alcoholic fatty liver in rats AMPK/SIRT1 pathway activation

The Anti-Diabetic, Lipidemic, And Pro-Inflammatory Effects of oral hypoglycemic on T2DM Obese Patients

NATURALLY DERIVED COMPOUNDS USED FOR PREVENTION OR REGRESSION OF EXPERIMENTALLY INDUCED LIVER FIBROSIS

Non-alcoholic fatty liver disease: Insights into pathogenesis, molecular mechanisms, and therapy

EVALUATION OF ANTIDIABETIC AND ANTI-OBESITY POTENTIAL AND SAFETY OF A POLYHERBAL REMEDY

Overview of key molecular processes behind diabetic nephropathy